NCT07788859

Brief Summary

Dual-tasking is performing two different tasks at the same time. For example, singing while cooking. Everyday activities often involve dual-task. In many researches evaluating dual-task performance in individuals with MS, it has been reported that individuals with severe disability, in particular, exhibit greater effort than healthy individuals. This increase in motor and cognitive dual-task performance in individuals with Multiple Sclerosis (MS) is associated with an increased risk of falls. There is a need for standardized, valid, and reliable assessment tools to evaluate dual-task performance in MS. The purpose of this study is to examine and compare the validity and reliability of the dual-task Timed Up and Go test administered using three different protocols.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
0mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Mar 2026Sep 2026

Study Start

First participant enrolled

March 16, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2026

Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

6 months

First QC Date

August 24, 2026

Last Update Submit

August 24, 2026

Conditions

Keywords

validityreliabilitydual-taskassessment toolstimed up and go test

Outcome Measures

Primary Outcomes (1)

  • Dual-task Timed up and go test (DTUG)

    The DTUG task will be evaluated in three different ways. The primary task will consist of the Timed Up and Go (TUG) test. The TUG test involves standing up from a chair, walking 3 meters, turning around, and sitting back down. While this test is being administered, secondary tasks will be performed simultaneously, and the time taken to complete the test will be recorded. The secondary tasks consist of a three-count backward counting task, verbal fluency, and a ball-carrying task on a tray.

    A single assessment will be administered to all participants at the end of the study. The assessment takes approximately 5 minutes.

Study Arms (1)

Patients with Multiple Sclerosis

Patients with Multiple Sclerosis aged between 18-65 years

Other: Intra-rater reliability analysisOther: Inter-rater reliability analysisOther: Convergent validity

Interventions

For the intra-rater reliability analysis, three DTUG protocols will be evaluated at 7- to 10-day intervals.

Patients with Multiple Sclerosis

For the inter-rater reliability analysis, three DTUG protocols will be administered to the same patient by two different physical therapists.

Patients with Multiple Sclerosis

To assess convergent validity, the relationship between the measurements from the three DTUG protocols and the results of other balance and functional mobility tests will be examined.

Patients with Multiple Sclerosis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from among individuals who visit the outpatient clinic of the Department of Neurology at SANKO University.

You may qualify if:

  • Having been diagnosed with MS according to the McDonald criteria revised in 2017,
  • Being between the ages of 18 and 65,
  • Having an Expanded Disability Status Scale (EDSS) score between 0 and 5.5,
  • Not requiring any assistive walking devices.

You may not qualify if:

  • Pregnancy;
  • Having experienced a relapse within the past three months;
  • The presence of another neurological condition in addition to MS;
  • The presence of a different disorder that could potentially affect gait parameters;
  • The presence of visual, auditory, perceptual, or cognitive impairments severe enough to interfere with the test administration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SANKO University

Gaziantep, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Hakan POLAT, PhD

    Sanko University

    STUDY CHAIR
  • Meltem UZUN, PhD

    Sanko University

    STUDY CHAIR
  • Suat EREL, PhD

    Pamukkale University

    STUDY CHAIR
  • Emel TAŞVURAN HORATA, PhD

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

EMEL TAŞVURAN HORATA, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

August 24, 2026

First Posted

August 27, 2026

Study Start

March 16, 2026

Primary Completion (Estimated)

September 14, 2026

Study Completion (Estimated)

September 14, 2026

Last Updated

August 27, 2026

Record last verified: 2026-08

Locations